Zdrowie i gospodarka · 15/03/2011
FDA Clears ROCEPHIN Ceftriaxone Sodium Injection for Sale
The FDA has determined that ROCEPHIN ceftriaxone sodium injection, approved under NDA 050585, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.